1. Home
  2. SPRY vs TPB Comparison

SPRY vs TPB Comparison

Compare SPRY & TPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRY
  • TPB
  • Stock Information
  • Founded
  • SPRY 2015
  • TPB 1988
  • Country
  • SPRY United States
  • TPB United States
  • Employees
  • SPRY N/A
  • TPB N/A
  • Industry
  • SPRY Biotechnology: Pharmaceutical Preparations
  • TPB Tobacco
  • Sector
  • SPRY Health Care
  • TPB Consumer Discretionary
  • Exchange
  • SPRY Nasdaq
  • TPB Nasdaq
  • Market Cap
  • SPRY 1.1B
  • TPB 1.1B
  • IPO Year
  • SPRY N/A
  • TPB 2016
  • Fundamental
  • Price
  • SPRY $12.57
  • TPB $57.60
  • Analyst Decision
  • SPRY Strong Buy
  • TPB Strong Buy
  • Analyst Count
  • SPRY 4
  • TPB 4
  • Target Price
  • SPRY $26.00
  • TPB $68.75
  • AVG Volume (30 Days)
  • SPRY 1.5M
  • TPB 191.6K
  • Earning Date
  • SPRY 11-13-2024
  • TPB 02-26-2025
  • Dividend Yield
  • SPRY N/A
  • TPB 0.49%
  • EPS Growth
  • SPRY N/A
  • TPB 283.79
  • EPS
  • SPRY N/A
  • TPB 2.48
  • Revenue
  • SPRY $2,568,000.00
  • TPB $409,407,000.00
  • Revenue This Year
  • SPRY $66,750.00
  • TPB $3.01
  • Revenue Next Year
  • SPRY $508.63
  • TPB $2.26
  • P/E Ratio
  • SPRY N/A
  • TPB $23.25
  • Revenue Growth
  • SPRY 8460.00
  • TPB 0.28
  • 52 Week Low
  • SPRY $6.00
  • TPB $21.98
  • 52 Week High
  • SPRY $18.51
  • TPB $66.18
  • Technical
  • Relative Strength Index (RSI)
  • SPRY 58.86
  • TPB 48.08
  • Support Level
  • SPRY $11.00
  • TPB $56.12
  • Resistance Level
  • SPRY $12.48
  • TPB $58.26
  • Average True Range (ATR)
  • SPRY 0.81
  • TPB 1.71
  • MACD
  • SPRY 0.28
  • TPB -0.28
  • Stochastic Oscillator
  • SPRY 84.95
  • TPB 46.89

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

About TPB Turning Point Brands Inc.

Turning Point Brands Inc operates as manufacturer, marketer, provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in three segments namely Zig-Zag products; Stoker's products and NewGen products. The company generates maximum revenue from the Zig-Zag products segment.

Share on Social Networks: